drugset
drugset / Trial / NCT01415895

Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain

NCT01415895 ↗

Phase 2 Completed 78 enrolled Annette C. Toledano MD
RandomizedParallel-groupDouble-blindTreatment

Summary

The study includes back pain of the cervical, thoracic, and the lumbar regions.

Timeline

Start
2011-07
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified — Oral
Subject Naltrexone Small molecule — Oral

Indications

No indication recorded.